Folate-responsive megaloblastic anemia (MEGAF) is a severe recurrent megaloblastic anemia caused by mutations in SLC19A1. It has been reported that the laboratory abnormalities and clinical signs were normalized only after adding folic acid to the patient's therapy. SLC19A1 encodes the reduced folate carrier (RFC) that facilitates the cellular uptake of anionic folates.
